Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 412.00K | 388.00K | 299.00K | 43.00K | 53.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 412.00K | 388.00K | 299.00K | 43.00K | 53.00K |
| Cost of Revenue | 230.00K | 242.00K | 25.00K | -- | -- |
| Gross Profit | 182.00K | 146.00K | 274.00K | 43.00K | 53.00K |
| SG&A Expenses | 2.13M | 2.22M | 1.52M | 1.80M | 2.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.81M | 2.84M | 1.88M | 2.11M | 2.62M |
| Operating Income | -2.40M | -2.45M | -1.58M | -2.07M | -2.56M |
| Income Before Tax | -2.48M | -2.64M | -1.83M | -12.93M | -3.78M |
| Income Tax Expenses | 1.00K | -- | 4.00K | -- | 2.00K |
| Earnings from Continuing Operations | -2.48M | -2.64M | -1.83M | -12.93M | -3.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.48M | -2.64M | -1.83M | -12.93M | -3.79M |
| EBIT | -2.40M | -2.45M | -1.58M | -2.07M | -2.56M |
| EBITDA | -2.37M | -2.41M | -1.58M | -2.05M | -2.56M |
| EPS Basic | -0.20 | -0.20 | -0.14 | -1.74 | -0.43 |
| Normalized Basic EPS | -0.11 | -0.11 | -0.09 | -0.81 | -0.21 |
| EPS Diluted | -0.20 | -0.20 | -0.14 | -1.74 | -0.43 |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.09 | -0.81 | -0.21 |
| Average Basic Shares Outstanding | 13.61M | 13.50M | 12.67M | 9.96M | 8.70M |
| Average Diluted Shares Outstanding | 13.61M | 13.50M | 12.67M | 9.96M | 8.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |